WADA PROHIBITED LIST

The World Anti-Doping Agency’s (WADA) Prohibited List is the comprehensive document serving as the international standard for identifying substances and methods prohibited in sport. Mandated by, and serving as a key component of, the Code, the Prohibited List is one of the most important parts of harmonization globally across the anti-doping movement. Broken down by categories, the Prohibited List identifies which substances and methods are prohibited in-competition, out-of-competition, as well as in some cases, by specific sport. The Prohibited List is updated annually following an extensive consultation process facilitated by WADA and goes into effect January 1 of each year. While the WADA Prohibited List is extensive, QADC is here to help clean athletes understand the rules and regulations set forth by WADA.

The easiest way to check the prohibited status of medications is to visit globaldro.com/

The following substances are placed on the 2023 Monitoring Program:

1. 1. Anabolic Agents: In and Out-of-Competition: Ecdysterone
2. Peptides Hormones, Growth Factors, Related Substances, and Mimetics: In and Out-of-Competition: Gonadotrophin-releasing hormone (GnRH) analogs in females under 18 years only.
3. Beta-2 Agonists: In and Out-of-Competition: Salmeterol and vilanterol below the Minimum Reporting Level.
4. Hypoxen (polyhydroxyphenylene thiosulfonate sodium): In and Out-of-Competition
5. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and synephrine.
6. Narcotics: In-Competition only: Codeine, dermorphin (and its analogs), hydrocodone and tramadol.